Study tests cheaper copycat drug for serious autoimmune disease
NCT ID NCT05716334
Summary
This study aimed to see if newer, more affordable 'biosimilar' versions of the drug rituximab work as well and are as safe as the original version for patients with two serious autoimmune diseases (GPA and MPA). Researchers followed 201 Canadian patients for two years, tracking their disease activity, side effects, and how long it took to get insurance approval for treatment. The goal was to provide real-world evidence to help doctors and patients choose between these treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA ASSOCIATED VASCULITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l'île-de-Montréal (CIUSSS NÎM) / Hôpital du Sacré-Coeur de Montréal
Montreal, Quebec, Canada
-
Lawson Research Institute (Western University)
London, Ontario, Canada
-
McGill University (Montreal General Hospital)
Montreal, Quebec, H3G 1A4, Canada
-
Ottawa Hospital Research Institute (Ottawa University)
Ottawa, Ontario, Canada
-
Sinai Health System (University of Toronto)
Toronto, Ontario, Canada
-
St Joseph's Healthcare Hamilton (McMaster University)
Hamilton, Ontario, Canada
-
University of Alberta
Edmonton, Alberta, Canada
-
University of British Columbia (Vancouver Coastal Health Authority)
Vancouver, British Columbia, Canada
-
University of Calgary
Calgary, Alberta, Canada
Conditions
Explore the condition pages connected to this study.